The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world evidence on treatment patterns and survival among ALK+ NSCLC patients in Canada who discontinue crizotinib treatment.
 
Sheena Kayaniyil
No Relationships to Disclose
 
Manjusha Hurry
Employment - Novartis
 
John Wilson
No Relationships to Disclose
 
Paul Wheatley-Price
Consulting or Advisory Role - Novartis
 
Barbara L. Melosky
Honoraria - Boehringer Ingelheim; Lilly; Pfizer
Research Funding - Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Jeffrey Rothenstein
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck; Novartis
 
Victor Cohen
Consulting or Advisory Role - AstraZeneca; Pfizer; Roche Canada
Speakers' Bureau - Pfizer
Research Funding - Pfizer
 
Caroline Koch
Employment - Novartis
Stock and Other Ownership Interests - Merck (I); Novartis
 
Jie Zhang
Employment - Johnson & Johnson (I); Novartis
Stock and Other Ownership Interests - Novartis
Other Relationship - Johnson & Johnson (I); Novartis
 
Katherine Osenenko
No Relationships to Disclose
 
Geoffrey Liu
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer; Roche